Arcanum Capital — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Arcana Network (operating as Avail Nexus) provides multi-chain infrastructure that lets decentralized applications operate across blockchains without rebuilding, including unified balances that combine tokens across chains and a verifiable data availability layer for high-throughput applications.
Crypto & Web3Data & InfrastructureDeveloper Tools
Mayur Relekar(Founder)in
Co-investorsCogitent VenturesDigital Currency GroupSymbolic CapitalWoodstock FundAU21 CapitalBuilders Tribe+4 more
Arcana provides fundamental and statistical factor models with portfolio analytics for equity investors, offering single-stock and portfolio-level factor decomposition, crowding and ownership data, risk attribution, and constraint-based portfolio optimization.
Data & InfrastructureFintechSaaSNew York, US
Rich Falk-Wallace(Founder)inSiva Sooriyan(Founder)in
Co-investorsAbstract VenturesPositive Sum CapitalSoma CapitalStratus VenturesUncommon Projects Capital ManagementAU21 Capital+7 more
KUDO provides a platform for remote simultaneous interpretation at conferences, offering certification and marketplace services for professional interpreters globally.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSNew York, US
Ewandro Magalhaes(Executive Officer)inFardad Zabetian(Executive Officer, Director)inAnnabelle Zabetian(Executive Officer)inParham Akhavan(Executive Officer)
BoardNiki Pezeshki(Director)
Co-investorsID8 InvestmentsAU21 CapitalBixin VenturesBTX CapitalLD CapitalMiH Ventures+1 more
ZippedScript offers AI-based technology for processing verifications, aiming for fast turnaround times.
AI & Machine Learning
Chris Harperin
Co-investorsNew Stack VenturesWork-Bench
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Lum Network
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















